Antao Chang

1.7k total citations
38 papers, 1.1k citations indexed

About

Antao Chang is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Antao Chang has authored 38 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 22 papers in Oncology and 12 papers in Immunology. Recurrent topics in Antao Chang's work include Cancer Cells and Metastasis (6 papers), Pancreatic and Hepatic Oncology Research (6 papers) and Cancer-related Molecular Pathways (5 papers). Antao Chang is often cited by papers focused on Cancer Cells and Metastasis (6 papers), Pancreatic and Hepatic Oncology Research (6 papers) and Cancer-related Molecular Pathways (5 papers). Antao Chang collaborates with scholars based in China, United States and Taiwan. Antao Chang's co-authors include Rong Xiang, Chongbiao Huang, Jihui Hao, Wenzhi Shen, Tiansuo Zhao, Xiuchao Wang, Peiqing Sun, Shengyu Yang, Shuang Yang and Chenghu Liu and has published in prestigious journals such as Nature Communications, Gastroenterology and Cancer Research.

In The Last Decade

Antao Chang

37 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Antao Chang China 19 617 390 338 294 117 38 1.1k
Lizhi He Canada 20 837 1.4× 344 0.9× 270 0.8× 283 1.0× 138 1.2× 38 1.4k
Baochi Ou China 17 602 1.0× 403 1.0× 302 0.9× 224 0.8× 70 0.6× 26 1.1k
Marianna Desideri Italy 22 919 1.5× 364 0.9× 310 0.9× 253 0.9× 122 1.0× 33 1.4k
Fiona Furlong Ireland 18 887 1.4× 326 0.8× 369 1.1× 170 0.6× 130 1.1× 34 1.3k
Johann S. Bergholz United States 18 681 1.1× 522 1.3× 197 0.6× 208 0.7× 117 1.0× 26 1.2k
Zhijun Zhou United States 20 662 1.1× 441 1.1× 386 1.1× 240 0.8× 64 0.5× 49 1.2k
Jianwu Tang China 19 707 1.1× 256 0.7× 264 0.8× 248 0.8× 117 1.0× 49 1.0k
Fabien Rodriguez Luxembourg 10 597 1.0× 463 1.2× 503 1.5× 197 0.7× 63 0.5× 11 1.1k
Rosa Martín‐Pérez Belgium 11 694 1.1× 311 0.8× 401 1.2× 618 2.1× 104 0.9× 15 1.2k

Countries citing papers authored by Antao Chang

Since Specialization
Citations

This map shows the geographic impact of Antao Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antao Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antao Chang more than expected).

Fields of papers citing papers by Antao Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antao Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antao Chang. The network helps show where Antao Chang may publish in the future.

Co-authorship network of co-authors of Antao Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Antao Chang. A scholar is included among the top collaborators of Antao Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antao Chang. Antao Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Jianming, Tiansuo Zhao, Xiuchao Wang, et al.. (2024). BICC1 drives pancreatic cancer stemness and chemoresistance by facilitating tryptophan metabolism. Science Advances. 10(25). eadj8650–eadj8650. 15 indexed citations
2.
Ge, Yi, Jing Liu, Zengxun Li, et al.. (2024). Tumor-derived interleukin 35 mediates the dissemination of gemcitabine resistance in pancreatic adenocarcinoma. Oncogene. 43(11). 776–788. 3 indexed citations
3.
Xie, Yongjie, Tianxing Zhou, Xueyang Li, et al.. (2024). Targeting ESE3/EHF With Nifurtimox Inhibits CXCR2+ Neutrophil Infiltration and Overcomes Pancreatic Cancer Resistance to Chemotherapy and Immunotherapy. Gastroenterology. 167(2). 281–297. 18 indexed citations
4.
Zou, Yiping, Tianxing Zhou, Yongjie Xie, et al.. (2023). Survival outcomes of neoadjuvant therapy followed by radical resection versus upfront surgery for stage I–III pancreatic ductal adenocarcinoma: a retrospective cohort study. International Journal of Surgery. 109(6). 1573–1583. 5 indexed citations
5.
Wu, Chao, Weihua Guo, Yongjie Xie, et al.. (2023). Combination of RUNX1 inhibitor and gemcitabine mitigates chemo‐resistance in pancreatic ductal adenocarcinoma by modulating BiP/PERK/eIF2α-axis-mediated endoplasmic reticulum stress. Journal of Experimental & Clinical Cancer Research. 42(1). 238–238. 15 indexed citations
6.
Liu, Yang, Shengyu Yang, Ran Zhao, et al.. (2023). Nuclear PLD1 combined with NPM1 induces gemcitabine resistance through tumorigenic IL7R in pancreatic adenocarcinoma. Cancer Biology and Medicine. 20(8). 1–28. 6 indexed citations
7.
Liu, Weishuai, Xiaozhou Yu, Yixing Feng, et al.. (2022). CD73, a Promising Therapeutic Target of Diclofenac, Promotes Metastasis of Pancreatic Cancer through a Nucleotidase Independent Mechanism. Advanced Science. 10(6). e2206335–e2206335. 22 indexed citations
8.
Zhao, Liang, Min Soo Kang, Xiaomeng Liu, et al.. (2022). UBR7 inhibits HCC tumorigenesis by targeting Keap1/Nrf2/Bach1/HK2 and glycolysis. Journal of Experimental & Clinical Cancer Research. 41(1). 330–330. 48 indexed citations
9.
Li, Shengnan, Lu Yang, Tiansuo Zhao, et al.. (2022). Perioperative Serum Scoring Systems Predict Early Recurrence and Poor Prognosis of Resectable Pancreatic Cancer. Frontiers in Oncology. 12. 841819–841819. 11 indexed citations
10.
Chang, Antao, Liang Liu, Dan Wu, et al.. (2021). Recruitment of KMT2C/MLL3 to DNA Damage Sites Mediates DNA Damage Responses and Regulates PARP Inhibitor Sensitivity in Cancer. Cancer Research. 81(12). 3358–3373. 39 indexed citations
11.
Wang, Qiong, Guanwen Wang, Shaorong Zhao, et al.. (2021). Exosomal MiR-1290 Promotes Angiogenesis of Hepatocellular Carcinoma via Targeting SMEK1. Journal of Oncology. 2021. 1–13. 48 indexed citations
12.
Wang, Guanwen, Juan Wang, Antao Chang, et al.. (2021). Correction to: Her2 promotes early dissemination of breast cancer by suppressing the p38 pathway through Skp2-mediated proteasomal degradation of Tpl2. Oncogene. 40(12). 2335–2335. 7 indexed citations
13.
Wang, Juan, Guanwen Wang, Dongmei Cheng, et al.. (2020). Her2 promotes early dissemination of breast cancer by suppressing the p38-MK2-Hsp27 pathway that is targetable by Wip1 inhibition. Oncogene. 39(40). 6313–6326. 9 indexed citations
14.
Huang, Shan, Xiaoli Dong, Yanan Chen, et al.. (2020). A novel isoform of ATOH8 promotes the metastasis of breast cancer by regulating RhoC. Journal of Molecular Cell Biology. 13(1). 59–71. 14 indexed citations
15.
Wang, Guanwen, Juan Wang, Antao Chang, et al.. (2020). Her2 promotes early dissemination of breast cancer by suppressing the p38 pathway through Skp2-mediated proteasomal degradation of Tpl2. Oncogene. 39(47). 7034–7050. 9 indexed citations
16.
Huang, Chongbiao, Yang Li, Zengxun Li, et al.. (2019). LIMS1 Promotes Pancreatic Cancer Cell Survival under Oxygen–Glucose Deprivation Conditions by Enhancing HIF1A Protein Translation. Clinical Cancer Research. 25(13). 4091–4103. 43 indexed citations
17.
Chen, Yanan, Wenjuan Gao, Antao Chang, et al.. (2017). Liposomal Nanoparticles Carrying anti-IL6R Antibody to the Tumour Microenvironment Inhibit Metastasis in Two Molecular Subtypes of Breast Cancer Mouse Models. Theranostics. 7(3). 775–788. 61 indexed citations
18.
19.
Chen, Chong, Lipeng Bai, Yan Liu, et al.. (2015). IKKβ Enforces a LIN28B/TCF7L2 Positive Feedback Loop That Promotes Cancer Cell Stemness and Metastasis. Cancer Research. 75(8). 1725–1735. 43 indexed citations
20.
Zhang, Chunyan, Nan Bai, Antao Chang, et al.. (2012). ATF4 is directly recruited by TLR4 signaling and positively regulates TLR4-trigged cytokine production in human monocytes. Cellular and Molecular Immunology. 10(1). 84–94. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lizhi He Breakdown of academic impact, for papers by Baochi Ou Breakdown of academic impact, for papers by Marianna Desideri Breakdown of academic impact, for papers by Fiona Furlong Breakdown of academic impact, for papers by Johann S. Bergholz Breakdown of academic impact, for papers by Zhijun Zhou Breakdown of academic impact, for papers by Jianwu Tang Breakdown of academic impact, for papers by Fabien Rodriguez Breakdown of academic impact, for papers by Rosa Martín‐Pérez
Rankless by CCL
2026